Deleterious effects of intravenous immunoglobulin in a patient with thrombotic thrombocytopenic purpura
Jean Marc Durand
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorPatrice Lefevre
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorGilles Kaplanski
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorFrederique Retornaz
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorElodie Cretel
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorJacques Soubeyrand
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorJean Marc Durand
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorPatrice Lefevre
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorGilles Kaplanski
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorFrederique Retornaz
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorElodie Cretel
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this authorJacques Soubeyrand
Department of Internal Medicine, CHU Sainte-Marguerite, Department of Haemobiology, CHU la Conception, Marseille, France
Search for more papers by this author
References
- 1 Lian ECY, Min PTK, Siddigui FA, Chiu AYY, Chiu LLS: Inhibition of plateletaggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. J Clin Invest 73: 548–555, 1984.
- 2 Gilcher RO: Refractory thrombotic thrombocytopenic purpura responding to intravenous gamma globulin. Blood 64(Suppl): 1237a, 1985.
- 3 Rose M, Eldor A: High incidence of relapses in thrombotic thrombocytopenic purpura. Am J Med 83: 437–444, 1987.
- 4 Kwaan HC: Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 24: 71–81, 1987.
- 5 Gordon LI, Kwaan HC, Rossi EC: Deleterious effects of platelet transfusions and recovery thrombosis in patients with thrombotic microangiopathy. Semin Hematol 24: 194–201, 1987.
- 6 Morrison J, McMillan R: Elevated platelet-associated IgG in thrombotic thrombocytopenic purpura. JAMA 235: 1944, 1977.
- 7 Reinard HW, Berchtold PE: Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet i: 662–664, 1992.
- 8
Wooddruff RK,
Grigg AP,
Firkin FC,
Smith IL:
Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients.
Lancet
ii: 217–218,
1986.
10.1016/S0140-6736(86)92511-0 Google Scholar
- 9 Durand JM, Lefevre P, Kaplanski G, Soubeyrand J: Ineffectiveness of high-dose intravenous gammaglobulin infusion in thrombotic thrombocytopenic purpura. A J Hematol 42: 234–234, 1993.
- 10 Finazzi G, Bellavita P, Falanga A, Viero P, Barbui T: Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Am J Hematol 41: 165–169, 1992.
Citing Literature
